Cargando…
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
Objective To investigate whether varenicline is associated with an increased risk of serious cardiovascular events compared with another drug used for smoking cessation, bupropion. Design Nationwide historical cohort study. Setting Denmark, 2007-10. Participants New users of varenicline (n=17 926) a...
Autores principales: | Svanström, Henrik, Pasternak, Björn, Hviid, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493624/ https://www.ncbi.nlm.nih.gov/pubmed/23138033 http://dx.doi.org/10.1136/bmj.e7176 |
Ejemplares similares
-
Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
por: Inghammar, Malin, et al.
Publicado: (2016) -
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
por: Svanström, Henrik, et al.
Publicado: (2014) -
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
por: Ueda, Peter, et al.
Publicado: (2018) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
por: Prochaska, Judith J, et al.
Publicado: (2012)